Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies

Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies

The use and interpretation of diagnostic cerebrospinal fluid (CSF) biomarkers for neurodegenerative disorders, such as Dementia with Lewy bodies (DLB), represent a clinical challenge. According to the literature, the composition of CSF in DLB patients varies. Some patients present with reduced level...

Full description

Bibliographic Details
Main Authors: Aikaterini Foska, Ioanna Tsantzali, Eleni Sideri, Maria Ioanna Stefanou, Eleni Bakola, Dimitrios K. Kitsos, Christina Zompola, Anastasios Bonakis, Sotirios Giannopoulos, Konstantinos I. Voumvourakis, Georgios Tsivgoulis, George P. Paraskevas
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Medicina
Subjects:
Dementia with Lewy bodies
Alzheimer’s disease
cerebrospinal fluid
biomarkers
tau
phospho-tau
Online Access:https://www.mdpi.com/1648-9144/58/5/612

Internet

https://www.mdpi.com/1648-9144/58/5/612

Similar Items